Literature DB >> 15205934

Microsatellite genotyping of chromosome 14q13.2-14q13 in the vicinity of proteasomal gene PSMA6 and association with Graves' disease in the Latvian population.

Tatjana Sjakste1, Jelena Eglite, Arturs Sochnevs, Mara Marga, Valdis Pirags, Yrjö Collan, Nikolajs Sjakste.   

Abstract

The 270-kb chromosome 14q13.2-14q13 region harboring the proteasomal alpha subunit 6 gene PSMA6 was analyzed for polymorphism of five microsatellite repeats in cases/controls and association with Graves' disease. Four novel microsatellite markers were localized to the 14q13.2 region upstream of PSMA6. Dinucleotide repeats HSMS801, HSMS702, HSMS701 were identified in two introns of the gene KIAA0391; the most upstream trinucleotide HSMS602 marker was found in an intron of the C14orf24 gene. A polymorphism study performed on the Latvian population revealed 13 and 14 alleles for HSMS801 and HSMS702, respectively, seven alleles for HSMS701, and four alleles for HSMS602. Heterozygosity analysis revealed that all the four markers obey Hardy-Weinberg distribution. The previously described HSMS006 marker, represented by 12 alleles, is localized in intron 6 of the PSMA6 gene. No significant differences were observed between patients and controls in allele distribution of the HSMS702 and HSMS701 microsatellite repeats. However, the allele frequencies of HSMS006 and HSMS801 were significantly different between Graves' disease and control subjects. The 181- and 185-bp alleles of HSMS006 and the 133-, 143-, and 149-bp alleles of HSMS801 were found more often, but the 189- and 191-bp alleles of HSMS006 were much less frequent in Graves' disease patients compared with the controls. An additional 174-bp allele of the HSMS602 marker, absent in healthy subjects, was found in Graves' disease patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15205934     DOI: 10.1007/s00251-004-0687-9

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  22 in total

1.  Exon/intron organisation of human proteasome PROS-27 K gene.

Authors:  T Sjakste; N Sjakste; K Scherrer
Journal:  DNA Seq       Date:  2001-11

2.  Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients.

Authors:  Takashi Akamizu; Hitomi Hiratani; Satoshi Ikegami; Stephen S Rich; Donald W Bowden
Journal:  J Hum Genet       Date:  2003-04-09       Impact factor: 3.172

3.  PDS is a new susceptibility gene to autoimmune thyroid diseases: association and linkage study.

Authors:  Hassen Hadj Kacem; Ahmed Rebai; Noureddine Kaffel; Saber Masmoudi; Mohamed Abid; Hammadi Ayadi
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

4.  Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: relevance of cross-population studies.

Authors:  M Marga; A Denisova; A Sochnev; V Pirags; N R Farid
Journal:  Am J Med Genet       Date:  2001-08-01

5.  Polymorphisms of HLA DQB1 CAR1/CAR2 and TNFalpha IR2/IR4 microsatellite markers in patients affected with Graves disease.

Authors:  A Maalej; H Hadj Kacem; M Bellassoued; M Abid; H Makni; H Ayadi
Journal:  Clin Immunol       Date:  2000-08       Impact factor: 3.969

6.  A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors:  C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

Review 7.  Genetic determinants of Graves disease.

Authors:  D A Chistyakov; K V Savost'anov; R I Turakulov; V V Nosikov
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

8.  Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501.

Authors:  J M Heward; A Allahabadia; M C Sheppard; A H Barnett; J A Franklyn; S C Gough
Journal:  Clin Endocrinol (Oxf)       Date:  1999-07       Impact factor: 3.478

9.  Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families.

Authors:  Yaron Tomer; Yoshiyuki Ban; Erlinda Concepcion; Giuseppe Barbesino; Ronald Villanueva; David A Greenberg; Terry F Davies
Journal:  Am J Hum Genet       Date:  2003-09-12       Impact factor: 11.025

10.  Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively.

Authors:  M M Le Beau; C Ito; P Cogswell; R Espinosa; A A Fernald; A S Baldwin
Journal:  Genomics       Date:  1992-10       Impact factor: 5.736

View more
  3 in total

1.  PSMA6 (rs2277460, rs1048990), PSMC6 (rs2295826, rs2295827) and PSMA3 (rs2348071) genetic diversity in Latvians, Lithuanians and Taiwanese.

Authors:  Tatjana Sjakste; Natalia Paramonova; Lawrence Shi-Shin Wu; Zivile Zemeckiene; Brigita Sitkauskiene; Raimundas Sakalauskas; Jiu-Yao Wang; Nikolajs Sjakste
Journal:  Meta Gene       Date:  2014-04-17

2.  Genetics of proteasome diseases.

Authors:  Aldrin V Gomes
Journal:  Scientifica (Cairo)       Date:  2013-12-30

3.  Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma.

Authors:  Yunan He; Sen Zeng; Shunjie Hu; Fengqian Zhang; Nianchun Shan
Journal:  Front Genet       Date:  2020-10-15       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.